The Association Between Obstructive Sleep Apnea Defined by 3 Percent Oxygen Desaturation or Arousal Definition and Self-Reported Cardiovascular Disease in the Sleep Heart Health Study.


Journal

Southwest journal of pulmonary & critical care
ISSN: 2160-6773
Titre abrégé: Southwest J Pulm Crit Care
Pays: United States
ID NLM: 101564087

Informations de publication

Date de publication:
2020
Historique:
entrez: 9 11 2020
pubmed: 10 11 2020
medline: 10 11 2020
Statut: ppublish

Résumé

Studies have established that OSA defined using a hypopnea definition requiring a ≥4% oxygen desaturation (AHI4%) is associated with cardiovascular (CVD) or coronary heart (CHD) disease. This study determined whether OSA defined using a hypopnea definition characterized by a ≥3% oxygen desaturation or an arousal (AHI3%A) is associated with CVD/CHD. Data were analyzed from 6307 Sleep Heart Health Study participants who had polysomnography. Self-reported CVD included angina, heart attack, heart failure, stroke, previous coronary bypass surgery or angioplasty. Self-reported CHD included the aforementioned conditions but not stroke or heart failure. The association between OSA and CVD/CHD was examined using logistic regression models with stepwise inclusion of demographic, anthropometric, social/behavioral and co-morbid medical conditions. A parsimonious model in which diabetes and hypertension were excluded because of their potential to be on the causal pathway between OSA and CVD/CHD also was constructed. For CVD, the odds ratios and 95% confidence intervals for AHI3%A ≥30/hour were 1.39 (1.03-1.87) and 1.45 (1.09-1.94) in the fully adjusted and parsimonious models. Results for CHD were 1.29 (0.96-1.74) and 1.36 (0.99-1.85). In participants without OSA according to more stringent AHI4% criteria but with OSA using the AHI3%A definition, similar findings were observed. OSA defined using an AHI3%A is associated with both CVD and CHD. Use of a more restrictive AHI4% definition will misidentify a large number of individuals with OSA who have CVD or CHD. These individuals may be denied access to therapy, potentially worsening their underlying CVD or CHD.

Sections du résumé

BACKGROUND BACKGROUND
Studies have established that OSA defined using a hypopnea definition requiring a ≥4% oxygen desaturation (AHI4%) is associated with cardiovascular (CVD) or coronary heart (CHD) disease. This study determined whether OSA defined using a hypopnea definition characterized by a ≥3% oxygen desaturation or an arousal (AHI3%A) is associated with CVD/CHD.
METHODS METHODS
Data were analyzed from 6307 Sleep Heart Health Study participants who had polysomnography. Self-reported CVD included angina, heart attack, heart failure, stroke, previous coronary bypass surgery or angioplasty. Self-reported CHD included the aforementioned conditions but not stroke or heart failure. The association between OSA and CVD/CHD was examined using logistic regression models with stepwise inclusion of demographic, anthropometric, social/behavioral and co-morbid medical conditions. A parsimonious model in which diabetes and hypertension were excluded because of their potential to be on the causal pathway between OSA and CVD/CHD also was constructed.
RESULTS RESULTS
For CVD, the odds ratios and 95% confidence intervals for AHI3%A ≥30/hour were 1.39 (1.03-1.87) and 1.45 (1.09-1.94) in the fully adjusted and parsimonious models. Results for CHD were 1.29 (0.96-1.74) and 1.36 (0.99-1.85). In participants without OSA according to more stringent AHI4% criteria but with OSA using the AHI3%A definition, similar findings were observed.
CONCLUSION CONCLUSIONS
OSA defined using an AHI3%A is associated with both CVD and CHD. Use of a more restrictive AHI4% definition will misidentify a large number of individuals with OSA who have CVD or CHD. These individuals may be denied access to therapy, potentially worsening their underlying CVD or CHD.

Identifiants

pubmed: 33163289
doi: 10.13175/swjpcc054-20
pmc: PMC7644074
mid: NIHMS1639173
doi:

Types de publication

Journal Article

Langues

eng

Pagination

86-103

Subventions

Organisme : NHLBI NIH HHS
ID : U01 HL053916
Pays : United States
Organisme : NHLBI NIH HHS
ID : R25 HL126140
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL063463
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA184920
Pays : United States
Organisme : NIMHD NIH HHS
ID : R01 MD011600
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL053941
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL128954
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL053937
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL095799
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG059202
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL053931
Pays : United States
Organisme : NHLBI NIH HHS
ID : UG3 HL140144
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL053938
Pays : United States
Organisme : NHLBI NIH HHS
ID : R61 HL151254
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL064360
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL053934
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL063429
Pays : United States
Organisme : NHLBI NIH HHS
ID : R56 HL138377
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI135108
Pays : United States

Références

J Thorac Dis. 2018 Dec;10(Suppl 34):S4201-S4211
pubmed: 30687536
Sleep Med. 2018 Apr;44:32-37
pubmed: 29530366
Am Heart J. 2019 Jun;212:134-143
pubmed: 31004916
Lancet. 2005 Mar 19-25;365(9464):1046-53
pubmed: 15781100
Am J Respir Crit Care Med. 2019 Aug 15;200(4):493-506
pubmed: 30764637
J Clin Sleep Med. 2019 Sep 15;15(9):1261-1270
pubmed: 31538597
Sleep. 1991 Dec;14(6):540-5
pubmed: 1798888
Am J Respir Crit Care Med. 2001 Jan;163(1):19-25
pubmed: 11208620
Sleep. 2004 May 1;27(3):536-40
pubmed: 15164911
J Clin Sleep Med. 2012 Oct 15;8(5):597-619
pubmed: 23066376
Arq Bras Cardiol. 2017 Jan;108(1):31-37
pubmed: 28146212
Sleep. 1997 Dec;20(12):1077-85
pubmed: 9493915
Sleep Med. 2020 Jul;71:39-46
pubmed: 32485597
J Clin Sleep Med. 2011 Dec 15;7(6):616-21
pubmed: 22171200
Sleep Breath. 2003 Mar;7(1):13-24
pubmed: 12712393
Hypoxia (Auckl). 2016 Apr 27;4:99-108
pubmed: 27800512
Sleep. 2006 Jun;29(6):777-83
pubmed: 16796216
Sleep. 2008 Aug;31(8):1071-8
pubmed: 18714778
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Sleep. 2008 Aug;31(8):1127-32
pubmed: 18714785
J Glob Health. 2018 Jun;8(1):010405
pubmed: 29497502
J Clin Sleep Med. 2019 Feb 15;15(2):183-194
pubmed: 30736872
Am J Respir Crit Care Med. 2009 Jun 15;179(12):1159-64
pubmed: 19264976
J Clin Sleep Med. 2020 Oct 15;16(10):1753-1760
pubmed: 32643602
J Clin Sleep Med. 2020 Jun 15;16(6):889-898
pubmed: 32043960
Sleep Med. 2003 Jan;4(1):29-33
pubmed: 14592357
J Diabetes. 2020 Jun;12(6):455-464
pubmed: 31872550
Respir Investig. 2020 Jan;58(1):7-20
pubmed: 31631059
Lancet Respir Med. 2015 Apr;3(4):310-8
pubmed: 25682233
Sleep. 1998 Nov 1;21(7):749-57
pubmed: 11286351

Auteurs

Stuart F Quan (SF)

Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Department of Medicine, University of Arizona College of Medicine, Tucson, AZ.

Rohit Budhiraja (R)

Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Sogol Javaheri (S)

Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Sairam Parthasarathy (S)

Department of Medicine, University of Arizona College of Medicine, Tucson, AZ.

Richard B Berry (RB)

Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, FL.

Classifications MeSH